Organogenesis Holdings Shares Owned By Institutions vs. Gross Profit

ORGO Stock  USD 3.60  0.08  2.17%   
Based on Organogenesis Holdings' profitability indicators, Organogenesis Holdings is performing exceptionally good at this time. It has a great odds to showcase excellent profitability results in January. Profitability indicators assess Organogenesis Holdings' ability to earn profits and add value for shareholders. At this time, Organogenesis Holdings' Price To Sales Ratio is very stable compared to the past year. As of the 11th of December 2024, EV To Sales is likely to grow to 2.33, while Days Sales Outstanding is likely to drop 51.53. At this time, Organogenesis Holdings' Interest Income is very stable compared to the past year. As of the 11th of December 2024, Change To Netincome is likely to grow to about 14.4 M, while Total Other Income Expense Net is likely to drop (2.2 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.580.7542
Way Down
Slightly volatile
For Organogenesis Holdings profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Organogenesis Holdings to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Organogenesis Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Organogenesis Holdings's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Organogenesis Holdings over time as well as its relative position and ranking within its peers.
  

Organogenesis Holdings' Revenue Breakdown by Earning Segment

Check out Your Equity Center.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
3.5
Earnings Share
(0.05)
Revenue Per Share
3.446
Quarterly Revenue Growth
0.061
Return On Assets
0.0164
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Organogenesis Holdings Gross Profit vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Organogenesis Holdings's current stock value. Our valuation model uses many indicators to compare Organogenesis Holdings value to that of its competitors to determine the firm's financial worth.
Organogenesis Holdings is rated below average in shares owned by institutions category among its peers. It is rated below average in gross profit category among its peers fabricating about  7,164,067  of Gross Profit per Shares Owned By Institutions. At this time, Organogenesis Holdings' Gross Profit is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organogenesis Holdings' earnings, one of the primary drivers of an investment's value.

Organogenesis Gross Profit vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Organogenesis Holdings

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
48.28 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Organogenesis Holdings

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
345.87 M
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Organogenesis Gross Profit Comparison

Organogenesis Holdings is currently under evaluation in gross profit category among its peers.

Organogenesis Holdings Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Organogenesis Holdings, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Organogenesis Holdings will eventually generate negative long term returns. The profitability progress is the general direction of Organogenesis Holdings' change in net profit over the period of time. It can combine multiple indicators of Organogenesis Holdings, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income12.5 M13.2 M
Net Income From Continuing Ops13 M13.6 M
Income Before Tax10.4 M10.9 M
Total Other Income Expense Net-2.1 M-2.2 M
Net Income Applicable To Common Shares17.9 M18.8 M
Net Income4.9 M5.2 M
Income Tax Expense5.4 M5.7 M
Net Interest Income-1.7 M-1.7 M
Interest Income10.3 M10.9 M
Non Operating Income Net Other-11.7 K-11.1 K
Change To Netincome13.7 M14.4 M
Net Income Per Share 0.04  0.04 
Income Quality 6.25  6.56 
Net Income Per E B T 0.48  0.45 

Organogenesis Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Organogenesis Holdings. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Organogenesis Holdings position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Organogenesis Holdings' important profitability drivers and their relationship over time.

Use Organogenesis Holdings in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Organogenesis Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will appreciate offsetting losses from the drop in the long position's value.

Organogenesis Holdings Pair Trading

Organogenesis Holdings Pair Trading Analysis

The ability to find closely correlated positions to Organogenesis Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Organogenesis Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Organogenesis Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Organogenesis Holdings to buy it.
The correlation of Organogenesis Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Organogenesis Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Organogenesis Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Organogenesis Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Organogenesis Holdings position

In addition to having Organogenesis Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large Value Funds Thematic Idea Now

Large Value Funds
Large Value Funds Theme
Funds or Etfs that invest in the undervalued stocks of large-sized companies. The Large Value Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Value Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Organogenesis Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Organogenesis Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organogenesis Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organogenesis Holdings Stock:
Check out Your Equity Center.
To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
To fully project Organogenesis Holdings' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Organogenesis Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Organogenesis Holdings' income statement, its balance sheet, and the statement of cash flows.
Potential Organogenesis Holdings investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Organogenesis Holdings investors may work on each financial statement separately, they are all related. The changes in Organogenesis Holdings's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Organogenesis Holdings's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.